Hims&Hers Hlth-A (HIMS)
$41.64
3.45 (8.29%)
HIMS Stock Quote Delayed 30 Minutes
The 3 Hottest Telehealth Stocks to Watch in 2024
Uncover the hottest telehealth stocks for 2024, on the back of a market projected to reach a whopping $504.2 billion by 2030.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$41.34
Market Cap
10.02B
PE Ratio
78.22
EPS
0.5323
Volume (Avg. Vol.)
29.81M
Day's Range
$40.14 - $45.31
52-Week Range
$11.20 - $72.98
Dividend & Yield
N/A (N/A)
HIMS Stock Predictions, Articles, and Hims&Hers Hlth-A News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!
Why Is Hims & Hers (HIMS) Stock Up 24% Today?
Hims & Hers (HIMS) stock is climbing higher on Tuesday after reporting results for the third quarter of 2022 and increasing guidance.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
HIMS Stock: 12 Reasons Why Hims & Hers Shares Are Soaring Today
Hims & Hers Health (HIMS) stock is soaring higher on Wednesday thanks to the company's earnings report for the fourth quarter of 2021.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! It's time for another busy day of investing with the biggest pre-market stock movers for Wednesday!
Buy Hims & Hers As It Falls Back Toward Prior Lows
Ignore the near-term pullback in Hims & Hers. With its unique business model, telehealth play HIMS stock remains a potential long-term winner.
This DTC Telemedicine Stock Has Enormous Potential Thanks to the $12 TRILLION Digital Healthcare Revolution
A small company by the name of Conversion Labs (NASDAQ:CVLB) will be the eBay or Alibaba of the DTC telemedicine platforms space.
Hims & Hers Stock Sits Where This Market Is Headed
Telehealth is the future, and Hims & Hers looks well-positioned for that future. Growth should keep the rally in HIMS stock going.
Is Hims & Hers Health a Good Way To Play the Telehealth Megatrend?
The prospects for HIMS stock look good. The company has certainly built a robust platform.
As It Goes Big on Telehealth, Hims & Hers Health Is a Buy on a Pull Back
If you believe in the future of telemedicine, then keep an eye on HIMS stock. It might not be in the buy zone yet, though, so be patient.
What’s Better? 1 Share of GameStop or 13 of Hims & Hers Health?
You can buy one share of GameStop or 13 shares of Hims & Hers Health. The smart money is buying HIMS stock at current prices.
Buy Hims & Hers Stock for a Solid Play on Telehealth
With its focus on millennials, fast growing telemedicine play HIMS stock has plenty of room to run after its recent SPAC merger.
Top SPAC Merger News This Week: Lucid Motors, EVgo, Joby Aviation and 7 More Hot SPACs
There was a lot of SPAC merger news for investors to digest this week. For a quick refresher, dive in with InvestorPlace.
HIMS Stock: 12 Things to Know as Telehealth Play Hims & Hers Starts Trading
Telehealth play HIMS stock makes its debut today. Here's what you should know about newly public Hims & Hers now.
